Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Houben

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Lung Cancer (Amsterdam, Netherlands)|February 18, 2014
EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?L E L Hendriks, E F Smit, B A H Vosse, et al.
The British Journal of Dermatology|September 28, 2021
Adcitmer<sup>®</sup> , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinomaC Esnault, V Leblond, C Martin, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Lung Cancer (Amsterdam, Netherlands)|February 18, 2014
EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?L E L Hendriks, E F Smit, B A H Vosse, et al.
The British Journal of Dermatology|September 28, 2021
Adcitmer<sup>®</sup> , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinomaC Esnault, V Leblond, C Martin, et al.
Pageof 4